DOKTERSPRACTIJK K. LUYCKX

Active

Private limited companyfounded 1997active for 29 yearsSint-Jorislaan 25, 2300 Turnhout, BelgiumKBO/BCE: BE 0461.387.626

Summary

DOKTERSPRACTIJK K. LUYCKX has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €358,042 and a net result of €78,176. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 79% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

DOKTERSPRACTIJK K. LUYCKXActiveChecked score 96/100

Risk analysis Report Compare

Activity

General medical practice

NACE 86210

1 site

Size

€414,298total assets 2025

Staff: 1.1 FTE
Equity: €358,042
Profit: €78,176

Turnover not published (micro format)

Financial health

96 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

2025 accounts 9 days early3 deeds in the Belgian Official Gazette

Why 96lowers riskLiquidity: current ratio 7.19, cash €134,183Sector: Human health activities (NACE 86)Equity €358,042 (86.4% of total assets)Figures for financial year 2025 (filed 22-07-2026)Show the evidence

Checked score

Score 2025

96 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 68% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 86.4% of total assets

Liquidity 88-5

short-term debt 13.6% · cash 32.4%

Profitability 92+3

return on assets 18.9%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €30,000 on 30-day terms is acceptable

Liquidity ample (current ratio 7.19, compared with 4.44 in 2024, above the usual 1.5; short-term debt: 13.6% and cash: 32.4% of total assets), and 13.6% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 72% on liquidity, 49% on profitability and 70% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Liquidity: current ratio 7.19, cash €134,183

NBB · annual accounts

Sector: Human health activities (NACE 86)

KBO

Equity €358,042 (86.4% of total assets)

NBB · annual accounts

Figures for financial year 2025 (filed 22-07-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

9 days early

2024

58 days early

2023

29 days early

2022

28 days early

2021

68 days early

2020

36 days early

2019

14 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

25-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

22-07-2026 Annual accounts filedfinancial year 2025 · micro…
31-12-2025 Highest result from 2018 to 2025net €78,176 ▲6.6%
03-06-2025 Annual accounts filedfinancial year 2024 · micro…

Key points

Positive: 8 profitable years in a rowprofit 2025: €78,176 8 years View
Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View
Positive: Equity rose in 2025from €281,532 to €358,042 ▲ 27.2% View

By topic

Financials

Financial year: 2025
Total assets: €414,298
Profit: €78,176
Solvency: 86.4%

Total assets▲ 15.2%

Net result

20182025

Go to Financials

Timeline

Events: 32
Since: 1999
Next accounts: by 31-07-2027

02-07-2024Annual accounts filed
03-07-2023Annual accounts filed
31-12-2022Liquidity more than doubled

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: General medical practiceNACE 86210
Founded: 08-09-1997
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about DOKTERSPRACTIJK K. LUYCKX

What is the company number of DOKTERSPRACTIJK K. LUYCKX?: 0461.387.626. In Belgium the VAT number is the company number with BE in front: BE 0461.387.626.
Where is DOKTERSPRACTIJK K. LUYCKX based?: The registered office is at Sint-Jorislaan 25, 2300 Turnhout.Company details
What does DOKTERSPRACTIJK K. LUYCKX do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOKTERSPRACTIJK K. LUYCKX?: Private limited company (BV).
When was DOKTERSPRACTIJK K. LUYCKX founded?: On 08-09-1997.
Is DOKTERSPRACTIJK K. LUYCKX still active?: Yes, DOKTERSPRACTIJK K. LUYCKX is an active enterprise in the KBO register.
How many employees does DOKTERSPRACTIJK K. LUYCKX have?: On average 1.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DOKTERSPRACTIJK K. LUYCKX?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is DOKTERSPRACTIJK K. LUYCKX profitable?: In financial year 2025, DOKTERSPRACTIJK K. LUYCKX made a profit of €78,176.
Where can I find the annual accounts of DOKTERSPRACTIJK K. LUYCKX?: DOKTERSPRACTIJK K. LUYCKX filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTERSPRACTIJK K. LUYCKX due?: By 31-07-2027, for financial year 2026.Timeline